The AI-powered technology can enable early screening at scale for a range of neurocognitive conditions, such as Alzheimer’s and mild cognitive impairment SANTA CLARA, Calif., May 25, 2021 /PRNewswire/ — Based on its recent analysis...
Read More
4 Minutes